Top Approvals Stories


Comment & Analysis »

GlobalData Healthcare

EMA withdrawal threatens UK patient access to cutting edge therapies

Brexit has thrown the future of British healthcare and Pharma into uncertainty, with the implications for funding, staffing and drug regulation largely unknown....

EMA withdrawal threatens UK patient access to cutting edge therapies
GlobalData Healthcare

AbbVie impresses with solid clinical data for its newest DAA regimen

AbbVie impresses with solid clinical data for its newest DAA regimen
GlobalData Healthcare

Trulance sNDA submission for IBS-C: a step forward for Synergy Pharmaceuticals

Trulance sNDA submission for IBS-C: a step forward for Synergy Pharmaceuticals
GlobalData Healthcare

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs
GlobalData Healthcare

PTC Therapeutics' Translarna fails phase III trial for cystic fibrosis

PTC Therapeutics' Translarna fails phase III trial for cystic fibrosis

Company Releases »

Critical Containment Products for the Pharmaceutical Industry

PBSC
Critical Containment Products for the Pharmaceutical Industry

Paediatric Clinical Trials 2016

SMI Paediatric Clinical Trials 2016

Approvals Insights »

Companies »